银屑病面积和严重度指数是心血管事件的独立危险因素:一项前瞻性登记研究
该前瞻性登记研究纳入767例中重度银屑病患者,共6264次PASI评分,链接住院与死因登记数据;校正10年心血管风险和既往心血管病后,PASI每增加1分与心血管事件的风险比为1.04(95%CI:1.01-1.07),提示PASI是未来心血管事件的独立标志物。
要点
- 中重度银屑病患者中,PASI每升高1分,心血管事件风险比为1.04(95%CI:1.01-1.07)。
- 校正10年心血管风险和既往心血管病后,PASI仍与心血管事件独立相关。
- 敏感性分析支持该关联的稳健性。
核心结论
- PASI是中重度银屑病患者未来心血管事件的独立标志物。
研究设计与样本
- 前瞻性登记研究,纳入767例中重度银屑病患者,共6264次PASI评分,并将PASI与心血管危险因素数据链接至基于人群的住院和死因行政数据。
主要发现
- 校正10年心血管风险和既往心血管病后,PASI每增加1分与心血管事件的风险比为1.04(95%CI:1.01-1.07)。
- 敏感性分析显示该关联稳健。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients treated with systemics for moderate-to-severe psoriasis have increased risk of cardiovascular disease (CVD). However, to the best of our knowledge, there are no data on the association between clinical disease activity and future cardiovascular events in this population. Such data could help identify patients at increased CVD risk and inform the potential for CVD prevention with effective psoriasis treatment. OBJECTIVE: To estimate the association between the Psoriasis Area and Severity Index (PASI) and cardiovascular events defined as hospitalization for CVD and cardiovascular death. METHODS: We linked prospectively collected data on PASI and CVD risk factors to population-based administrative data on hospitalizations and causes of death. We estimated the association between PASI and cardiovascular events using Cox proportional hazard models with PASI and Framingham 10-year cardiovascular risk as time-varying covariates. RESULTS: A total of 767 patients with 6264 PASI scores were included. After adjusting for 10-year cardiovascular risk and prior CVD, a one-point increase in PASI was associated with a hazard ratio of 1.04 (95% CI: 1.01-1.07) for cardiovascular events. The findings were robust in sensitivity analyses. CONCLUSION: PASI is an independent marker for future cardiovascular events in patients with moderate-to-severe psoriasis.
引用
- Svedbom A, Ståhle M. The psoriasis area and severity index is an independent risk factor for cardiovascular events: A prospective register study. J Eur Acad Dermatol Venereol. 2023. PMID: 37147891. doi:10.1111/jdv.19168
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。